Regenerative Medicine Using Pregnancy-Specific Biological Substances

ISBN-13: 9781848827172 / Angielski / Twarda / 2010 / 460 str.

Niranjan Bhattacharya; Phillip Stubblefield

Opis

The proposed book is a holistic review of the clinical use of placental substances, amniotic fluid, the umbilical cord and its contents. It is intended to be a unique presentation of the current advances as well as also discussing the future applications of these substances. Attention is yet to be focused on the widespread clinical use of pregnancy-related biological substances . The aim for this book is to inform clinicians of the use of such materials and increase awareness of their therapeutic benefits. As such, this reference resource will be of great value to hematologists, rheumatologists, cardiologists, transplant technologists and all involved in regenerative medicine.

Recenzje

From the reviews:

"This book describes clinical and preclinical research involving the use of the human umbilical cord, amnion, and placenta for regenerative medicine. It contains a wealth of information and new ideas. ... It is written for clinicians and basic science researchers interested in pregnancy and regenerative medicine ... . documents innovative approaches to regenerative medicine using cord blood and other pregnancy-associated substances. Carefully edited, it provides a fascinating snapshot of current research. This is an important topic that is not often addressed." (Bruce A. Fenderson, Doody's Review Service, January, 2012)

Spis treści

Foreword

Section 1

Massive wastage of Pregnancy Specific biological substances

1. Massive Wastage of the Global Resources

Section 2:

Basic science and Placental use

2. Placenta as a source of stem cells and as a key organ for fetomaternal tolerance
3. Use of Placenta as Medicine: Placenta and Umbilical Cord in Traditional Chinese

Medicine

Section 3:

Cardiovascular and angiology

4. Umbilical vein graft for lower limb revascularisation
5. Use of umbilical venous blood on assessing the biochemical variations of acid-base, nutritional and metabolic parameters on growth-retarded fetuses, in comparison with gestational control cases: A study.
6. Cord Blood Stem Cells in Angiogenesis
7. Endothelial Progenitor Cells From Cord Blood: Magic Bullets Against Ischemia?

Section 4:

Cord blood Transfusion perspectives

8. Use of Placental Umbilical cord blood in transfusion Medicine
9. Use of Placental Umbilical cord blood in Paediatrics
10. Clinical Experience of Cord blood autologous transfusion 
11. Emergency Use of Human Cord Blood 
12. hemoglobin based oxygen carriers in trauma CARE: The U. S. Multicenter Prehosptial trial.
13. Cord blood as transfusion substitute in Emergency.

Section 5:

Use of Placental Umbilical cord blood in subspecialities of Regeneration medicine in neurology

14. Anti-inflammatory effects of human cord blood and its potential implication in neurological disorders 
15. Transforming "waste" into gold: Identification of Novel stem cell resources with therapeutic potential in neuromuscular disorders
16. Human Umbilical Cord Blood Cells for Stroke
17. Cord blood in Neurology

Section 6:

Immunotherapy potential of Fetal Cell in Maternal System

18. Implications of feto-maternal cell transfer in normal pregnancy
19. Immunotherapy potential of Cord blood transfusion in cases of advanced breast Cancer

Section 7:

Use of Placental Umbilical cord blood in Orthopaedics

20. Cord Blood – An alternative source for bone regeneration 

Section 8:

Use of Placental Umbilical cord blood serum in Opthalmology

21. Umbilical Cord Blood Use in Opthalmology

Section 9:

Use of Placental Umbilical cord blood in Cardiology

22. Therapeutic Potential of Placental Umbilical Cord Blood in Cardiology
23. Cord Blood in Cardiology
24. Cord blood in Myocardial infarction

Section 10:

Use of Placental Umbilical cord blood in other subspecialities of Regeneration Medicine

25. Umbilical cord-derived mesenchymal stem cells
26. Cord Blood Stem Cell Expansion ex vivo: Current Status and Future Strategies
27. Advances in cord blood regeneration
28. Use of Non-hematopoietic stem cells of fetal origin from cord blood, umbilical cord and placenta in Regeneration Medicine
29. Animal Studies of Cord Blood and Regeneration
30. Immune privileges of Cord Blood
31. Cord Blood in Regenerative Medicine: Recent advances

Section 11:

Clinical use of Amniotic fluid

32. Placenta and amniotic fluid: a massive wastage of human resources - a perspective on its current and potential use
33. Use of Amniotic fluid in non healing ulcer dressing

Section 12:

Cord blood collection variability and Banking

34. Comparisons between Related and Unrelated Cord Blood Collection and/or Banking for Transplantation or Research
35. Donor and Collection-related Variables Affecting Product Quality in Ex-utero Cord Blood Banking
36. Collection of cord blood as a source of hematopoietic progenitors for transplantation

Section 13:

Ethics

37. Ethical issues surrounding Umbilical Cord Blood donation and banking

Blurb

Regenerative Medicine Using Pregnancy Specific Biological Substances is an international attempt to bring researchers working on the potential uses of pregnancy specific biological substances in regenerative medicine, under one umbrella. More than 72 distinguished authors from five continents have contributed in the 40 chapters of the book. It will be a good reference source, not only for practicing clinicians, but also for those interested in research in immunotherapy; stem cell therapy; regenerative therapy and various specialities such as cardiology, neurosurgery and cardiothoracic surgery. This book brings together some of the important work that is being done along with unpublished observations that will help to shape the contours of future therapy in the field of modern regenerative medicine. It promises to be an eye-opener to the enormous potential of hitherto discarded material that had been so far considered as a pure biological waste. The book will have served its purpose if it acts as a stimulant to professionals and clinical scientists who can build on the knowledge and expand the curative potential of pregnancy-specific biological substances